Showing 1 - 4 results of 4 for search 'François Petitpierre', query time: 0.03s Refine Results
  1. 1
    Clinical, Technical, and MRI Features Associated with Patients’ Outcome at 3 Months and 2 Years following Prostate Artery Embolization: Is There an Added Value of Radiomics?

    Clinical, Technical, and MRI Features Associated with Patients’ Outcome at 3 Months and 2 Years following Prostate Artery Embolization: Is There an Added Value of Radiomics? by Antoine Martin, Clément Marcelin, François Petitpierre, Eva Jambon, Rim Maaloum, Nicolas Grenier, Yann Le Bras, Amandine Crombé

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Prostate Artery Embolization Using N-Butyl Cyanoacrylate Glue for Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Valid Alternative to Microparticles?

    Prostate Artery Embolization Using N-Butyl Cyanoacrylate Glue for Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Valid Alternative to Microparticles? by Romaric Loffroy, Kévin Guillen, Etienne Salet, Clément Marcelin, Pierre-Olivier Comby, Marco Midulla, Nicolas Grenier, Olivier Chevallier, François Petitpierre

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Practical clinical and radiological models to diagnose COVID-19 based on a multicentric teleradiological emergency chest CT cohort

    Practical clinical and radiological models to diagnose COVID-19 based on a multicentric teleradiological emergency chest CT cohort by Paul Schuster, Amandine Crombé, Hubert Nivet, Alice Berger, Laurent Pourriol, Nicolas Favard, Alban Chazot, Florian Alonzo-Lacroix, Emile Youssof, Alexandre Ben Cheikh, Julien Balique, Basile Porta, François Petitpierre, Grégoire Bouquet, Charles Mastier, Flavie Bratan, Jean-François Bergerot, Vivien Thomson, Nathan Banaste, Guillaume Gorincour

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trialResearch in context

    Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trialRese... by Marc Sapoval, Nicolas Thiounn, Aurélien Descazeaud, Carole Déan, Alain Ruffion, Gaële Pagnoux, Ricardo Codas Duarte, Grégoire Robert, Francois Petitpierre, Gilles Karsenty, Vincent Vidal, Thibaut Murez, Hélène Vernhet-Kovacsik, Alexandre de la Taille, Hicham Kobeiter, Romain Mathieu, Jean-Francois Heautot, Stéphane Droupy, Julien Frandon, Nicolas Barry Delongchamps, Virginie Korb-Savoldelli, Isabelle Durand-Zaleski, Helena Pereira, Gilles Chatellier, Olivier Pellerin, Brigitte Sabatier, Charles Dariane, Benjamin Gabay, Paul Cezar Moldovan, Olivier Rouvière, Jean Champagnac, Samuel Lagabrielle, Nicolas Grenier, Romain Boissier, Éric Lechevallier, Jalal-Jean Izaaryene, Farouk Tradi, Raphaele Arrouasse, Julien Defontaines, Xavier Joseph, Philippe Le Corvoisier, Emilie Sbidian, Cécile Champy, Mélanie Chiaradia, Armand Chevrot, Cyrille Blion, Jean Goupil, Julie Bulsei, Alexandra Vappereau

    Published 2023-08-01
    Get full text
    Article

Search Tools: